Richard L. Schilsky, Dina L. Michels, Peter Paul Yu (president elect), and Clifford A. Hudis (president), American Society of Clinical Oncology, Alexandria, VA; Amy H. Kearbey, McDermott Will & Emery, Washington, DC; Peter Paul Yu, Palo Alto Medical Foundation, Palo Alto, CA; and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY.
J Clin Oncol. 2014 Aug 1;32(22):2373-9. doi: 10.1200/JCO.2014.56.2124. Epub 2014 Jun 9.
Today is a time of unprecedented opportunity and challenge in health care generally and cancer care in particular. An explosion of scientific knowledge, the rapid introduction of new drugs and technologies, and the unprecedented escalation in the cost of health care challenge physicians to quickly assimilate new information and appropriately deploy new advances while also delivering efficient and high-quality care to a rapidly growing and aging patient population. At the same time, big data, with its potential to drive rapid understanding and innovation, promises to transform the health care industry, as it has many others already. CancerLinQ is an initiative of the American Society of Clinical Oncology (ASCO) and its Institute for Quality, developed to build on these opportunities and address these challenges by collecting information from the electronic health records of large numbers of patients with cancer. CancerLinQ is, first and foremost, a quality measurement and reporting system through which oncologists can harness the depth and power of their patients' clinical records and other data to improve the care they deliver. The development and deployment of CancerLinQ raises many important questions about the use of big data in health care. This article focuses on the US federal regulatory pathway by which CancerLinQ will accept patient records and the approach of ASCO toward stewardship of the information.
如今，医疗保健领域，特别是癌症护理领域正面临着前所未有的机遇和挑战。科学知识的爆炸式增长、新药和新技术的快速引入，以及医疗保健成本的空前攀升，都要求医生们迅速掌握新信息，合理应用新进展，同时为快速增长和老龄化的患者群体提供高效、高质量的护理。与此同时，大数据有可能推动快速理解和创新，有望像已经改变许多其他行业一样，改变医疗保健行业。CancerLinQ 是美国临床肿瘤学会（ASCO）及其质量研究所的一项倡议，旨在利用这些机会并应对这些挑战，方法是从大量癌症患者的电子健康记录中收集信息。CancerLinQ 首先是一个质量衡量和报告系统，通过该系统，肿瘤学家可以利用患者临床记录和其他数据的深度和力量来改善他们提供的护理。CancerLinQ 的开发和部署引发了许多关于在医疗保健中使用大数据的重要问题。本文重点介绍了 CancerLinQ 将接受患者记录的美国联邦监管途径，以及 ASCO 对信息管理的方法。
